Cancer Policy (Record no. 28220)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01910nam a22002657a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20240809174659.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | 20240809174659.0 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20240809175115.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 240809b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-43896-2 |
| International Standard Book Number | 978-3-319-43894-8 |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0927-3042 |
| International Standard Serial Number | 2509-8497 |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Relator term | June M. McKoy |
| 245 ## - TITLE STATEMENT | |
| Title | Cancer Policy |
| Remainder of title | Pharmaceutical Safety |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Feinberg School of Medicine Northwestern University Chicago, IL, USA : |
| Name of publisher, distributor, etc. | Springer Nature Switzerland AG : |
| Date of publication, distribution, etc. | 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 129 Pages |
| 490 ## - SERIES STATEMENT | |
| Series statement | https://doi.org/10.1007/978-3-319-43896-2 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Medical / Clinical Medicine, Medical / Oncology / General, Medical / Pharmacology, Oncology, Pharmacovigilance, Cancer -- Treatment, Drugs -- Safety measures, Medical policy, Pharmaceutical industry, Pharmaceutical policy, Pharmacy |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Relator term | Dennis P. West |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 08/09/2024 | 20240809174659.0 | 08/09/2024 | 08/09/2024 | E-BOOKS |